1360PPhase II trial of AZD9291 in second line treatment after acquired resistance with T790M mutation detected from circulating tumor DNA (LiquidLung-O-Cohort 2)
Kim, Y-C., Park, C.K., Oh, I-J., Lim, J-H., Choi, Y-D., Cho, H., Ahn, S-J., Song, S-Y., Yun, J.S., Na, K-J.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.062
Date:
September, 2017
File:
PDF, 81 KB
english, 2017
File converter
More search results
More benefits 
